Yoga Therapy for management of chronic low back pain

Effectiveness of Integrated Approach of Yoga Therapy (IAYT) versus usual care in management on Chronic Low Back Pain Patients: A Randomized Controlled Pilot Study

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024951

Enrollment

Registered

2020-04-30

Start date

Unknown

Completion date

Unknown

Last updated

2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Integrated approach of Yoga therapy (IAYT): A series of 60 minutes Integrated approach of Yoga therapy (IAYT) class (for a span of 15 days), using all of the components of yoga at the

Eligibility

Inclusion criteria

Inclusion criteria: Adults indicative of low back pain with or without leg pain for more than 3 months, Average pain intensity of = 4 on a Numeric Rating scale (NRS), Participants who are willing to participate, Who are ready to travel and attend yoga classes, and are willing to continue home practise

Exclusion criteria

Exclusion criteria: - Pain due to organic causes such as infective and inflammatory conditions, or degenerative disorders of the muscles. - Critically ill and is unable to participate due to severe pain. - Patients diagnosed with fixed lumbar spinal canal stenosis or sacroiliac joint dysfunction. - Severe Obesity - Chronic pain occurred due to cancer or involvement of fibromyalgia, diabetic neuropathy and other systematic complications such as cardiac, kidney disorders. - Patients who have undergone lower back region surgery. - Patients with pre-existing psychiatric illness

Design outcomes

Primary

Measure	Time frame
Functional Disability measured using Modified Oswestry Disability Index (MODI)Timepoint: At 3 monts	—

Secondary

Measure	Time frame
Pain assessed using VNRS, DN4 and PCS, mental Health using HADS, Quality of Life using EuroQol and measure fear of movement i.e. Kinesiophobia using TAMPA Scale and patient global impression clinical improvement to measure of the overall clinical benefit from the treatment. Potential Pain Biomarkers using blood serum ß – Endorphins, TNF – a and salivary assessment of CGRF will help us derive the effects of IAYT regime on pain and these biomarkers themselvesTimepoint: Baseline. 15 days, one month and 3 months all except pain biomarkers which will be assessed at baseline 1 month and 3 months	—

Measure

Time frame

Pain assessed using VNRS, DN4 and PCS, mental Health using HADS, Quality of Life using EuroQol and measure fear of movement i.e. Kinesiophobia using TAMPA Scale and patient global impression clinical improvement to measure of the overall clinical benefit from the treatment. Potential Pain Biomarkers using blood serum ß – Endorphins, TNF – a and salivary assessment of CGRF will help us derive the effects of IAYT regime on pain and these biomarkers themselvesTimepoint: Baseline. 15 days, one month and 3 months all except pain biomarkers which will be assessed at baseline 1 month and 3 months

—

Countries

India

Contacts

Public ContactSpoorthi Poojari

Post Graduate Institute of Medical Education and Research, Chandigarh

ghaibabita1@gmail.com7087009533

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026